This inventor holds 21 USPTO granted patents and 8 published patent applications and 2 EPO patents, primarily in Myostatin Modulation. Top assignees: Scholar Rock, Inc., Curis, Inc., Cambridge Neuroscience, Inc.. Active years: 1997-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
14 out of 34 
4 out of 141 
2 out of 43 
Years Active: 1997-2026
Areas of Expertise:
Title: Nagesh K Mahanthappa: Innovator in Antibody and Growth Factor Development
Introduction
Nagesh K Mahanthappa is a prominent inventor based in Cambridge, MA, recognized for his significant contributions to the field of biotechnology. With an impressive portfolio of 18 patents, he has dedicated his career to advancing medical science through innovative research and development focused on antibodies and growth factors.
Latest Patents
Mahanthappa’s latest patents showcase his cutting-edge work in biotechnology. One such patent is titled "Compositions for making and using anti-Myostatin antibodies." This patent describes antibodies that specifically bind to proMyostatin and/or latent Myostatin, along with their various uses. Another noteworthy patent, "Compositions and methods for growth factor modulation," provides insights into proteins, antibodies, assays, and methods that can modulate growth factor levels and activities. These growth factors are crucial members of the TGF-β superfamily of proteins, influencing numerous biological processes.
Career Highlights
Throughout his career, Mahanthappa has held key positions at several leading biotechnology companies. He has worked at Scholar Rock, Inc., where he contributed to the development of innovative therapeutic solutions. Additionally, his tenure at Curis, Inc. further solidified his reputation as a pioneer in the field.
Collaborations
Nagesh has collaborated with several notable coworkers, including Michelle Marie Straub and Thomas Schurpf. These partnerships have allowed him to leverage collective expertise, driving forward innovative solutions in biotechnology.
Conclusion
With 18 patents to his name, Nagesh K Mahanthappa continues to make significant strides in biotechnology. His latest work on anti-Myostatin antibodies and growth factor modulation reflects his commitment to enhancing understanding and treatment options in medical science. As an inventor, his contributions are invaluable, paving the way for future advancements in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile